Blaszyk Michael D
CIK 0001371407
Director
Filings
6
Latest Jun 20, 2025
Issuers covered
2
Showing
6 of 6
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -2.5% | -2.5% | -2.5% | -2.5% |
| 90 days | 3 | 0% | -47.7% | -47.7% | -47.7% | -47.7% |
| 180 days | 3 | 100% | +33.3% | +33.3% | +33.3% | +33.3% |
| 365 days | 3 | 100% | +120.4% | +120.4% | +120.4% | +120.4% |
Issuers
Companies where Blaszyk Michael D has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IBRX | Immunitybio, Inc. | 5 | Jun 20, 2025 |
| NHIQ | Nanthealth, Inc. | 1 | Jun 10, 2022 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|